Xanodyne (Rights to Amicar) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Xanodyne (Rights to Amicar) General Information
Description
Drug formulation for treatment of bleeding disorder. The drug is used for treatment for bleeding disorder in case of surgical complication.
Contact Information
Corporate Office
- One Riverfront Place
- Newport, KY 41071
- United States
Corporate Office
- One Riverfront Place
- Newport, KY 41071
- United States
Xanodyne (Rights to Amicar) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xanodyne (Rights to Amicar) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Xanodyne (Rights to Amicar) FAQs
-
Where is Xanodyne (Rights to Amicar) headquartered?
Xanodyne (Rights to Amicar) is headquartered in Newport, KY.
-
What industry is Xanodyne (Rights to Amicar) in?
Xanodyne (Rights to Amicar)’s primary industry is Buildings and Property.
-
Is Xanodyne (Rights to Amicar) a private or public company?
Xanodyne (Rights to Amicar) is a Private company.
-
What is Xanodyne (Rights to Amicar)’s current revenue?
The current revenue for Xanodyne (Rights to Amicar) is .
-
Who are Xanodyne (Rights to Amicar)’s investors?
Xanodyne Pharmaceuticals has invested in Xanodyne (Rights to Amicar).
-
When was Xanodyne (Rights to Amicar) acquired?
Xanodyne (Rights to Amicar) was acquired on 01-Aug-2012.
-
Who acquired Xanodyne (Rights to Amicar)?
Xanodyne (Rights to Amicar) was acquired by VersaPharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process